CrushSCI.com
Journal Selection & Manuscript Polishing Services
American Journal of Cardiovascular Drugs journal cover Medicine
Back to journal directory

Review Cycle Records

American Journal of Cardiovascular Drugs

Springer SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 32025 JCR Q2
177.2Average days
186Median days
30Fastest days
373Longest days
672025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

239 days

Comparative Effectiveness of Sacubitril/Valsartan Versus Sodium-Glucose Cotransporter 2 Inhibitors among Patients with Heart Failure with Reduced Ejection Fraction with or without Diabetes: A Cohort Study

AuthorsMunaza Riaz; Steven M. Smith; David E. Winchester; Eric A. Dietrich; Haesuk Park

Affiliations1. Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA; 2. Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA; 3. Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, USA; 4. Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, Gainesville, USA

Source PDF DOI Publisher page
68 days

When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes

AuthorsZeyad Elariny; Omar Salem; Mohamad Ashraf Salaheldin; Adham Ahmed; Farida Rabie; Maryam Mohamed Sayed; Mohamed Harish; Mohamed Ali; Selim Ahmed Eliwa; Mohammad Elshorbagy; Sara ElHarouni; Ahmed Abdelmeguid; Retaj Ahmed; Omnia Azmy Nabeh

Affiliations1. Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt; 2. Faculty of Medicine, Benha National University, Obour City, Egypt; 3. Lecturer of Pharmacology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt

Source PDF DOI Publisher page
126 days

Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis

AuthorsAnastasios Apostolos; Konstantinos Konstantinou; Mohammed Allaf; Athanasios Sakalidis; Konstantinos Kalogeras; Ee Ling Heng; Simon Davies; Alison Duncan; Miles Dalby; Saeed Mirsadraee; Tarun Mittal; Aigul Baltabaeva; Tito Kabir; Mohammed Majid Akhtar; Robert Smith; Vasileios Panoulas

Affiliations1. Royal Brompton and Harefield Hospitals, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK; 2. Faculty of Medicine, Imperial College London, London, UK; 3. National Heart and Lung Institute, Imperial College London, London, UK

Source PDF DOI Publisher page
257 days

Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes

AuthorsFatemeh Baharvand; Roxana Mehran; Francesca Maria Di Muro; Alieh Mohammadi; Mohammadreza Aghajankhah; Shiva Parvaneh; Niloufar Akbari Parsa; Soheil Hassanipour; Ehsan Aboutaleb; Yaser Jenab; Somayeh Bashiri Aliabadi

Affiliations1. Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran; 2. The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 3. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; 4. Department of Pharmaceutics, School of pharmacy, Guilan University of Medical Sciences, Rasht, Iran; 5. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source PDF DOI Publisher page
105 days

Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers

AuthorsDaniel Lachant; Cristian E. Botta; George Giannakoulas; Natalie Patzlaff; Scott Seaman; Meredith Broderick; Maria Guido; Søren Mellemkjær; Zeenat Safdar

Affiliations1. University of Rochester Medical Center, Rochester, USA; 2. Department of Heart Failure and Pulmonary Arterial Hypertension, Sanatorio Privado San Gerónimo, Santa Fe, Argentina; 3. Aristotle University of Thessaloniki, Thessaloniki, Greece; 4. United Therapeutics Corp, Durham, USA; 5. UC Health, Cincinnati, USA; 6. Aarhus University Hospital, Aarhus, Denmark; 7. Houston Methodist Lung Center, Houston, USA; 8. HMRI, Houston, USA; 9. Weill Cornell College of Medicine, New York, USA; 10. Texas A&M College of Medicine, Bryan, USA

Source PDF DOI Publisher page
373 days

Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review

AuthorsErfan Shahabinejad; Fatemeh Soflaei-Shahrbabak; Marzieh Gholami Shoa; Aida Azhdarimoghaddam; Mehrdad Mozafar; Pouya Yektaee-Rad; Samar Monajemi; Shayan Ghanouni; Shuhao Qiu; Mani Khorsand Askari

Affiliations1. Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2. USERN Office, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 3. Faculty of Pharmacy, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran; 4. Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran; 5. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 6. Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran; 7. Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran; 8. Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; 9. Department of Medicine, University of Toledo, Toledo, USA

Source PDF DOI Publisher page
100 days

Combination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies

AuthorsChristopher Daniel Tristan; Irnizarifka Irnizarifka; Erlangga Masykur Kynaya; Mellisa Gani; Matthew Aldo Wijayanto; An Aldia Asrial; Raymond Pranata

Affiliations1. Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia; 2. Department of Cardiology and Vascular Medicine, Universitas Sebelas Maret–Sebelas Maret Hospital, Surakarta, Indonesia; 3. Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; 4. Department of Cardiovascular Medicine, Siloam Lippo Village Hospital, Tangerang, Indonesia

Source PDF DOI Publisher page
152 days

GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-Analysis

AuthorsPedro Gomes Batista; Railla Raquel Albino dos Santos Silva; Marcela Vasconcelos Montenegro; Mushrin Malik; Mrunalini Dandamudi; Juan Peres de Oliveira; Maria Eduarda Molinari; Larissa Araujo de Lucena; Ramon Huntermann; Juliana Giorgi; Caroline O. Fischer Bacca

Affiliations1. Federal University of Paraíba, João Pessoa, Brazil; 2. Federal University of Ceará, Fortaleza, Brazil; 3. University of Pernambuco, Recife, Brazil; 4. Beth Israel Deaconess Medical Center, Boston, USA; 5. Montefiore Einstein Medical Center, Bronx, USA; 6. University Center for the Development of Alto Vale, Rio do Sul, Brazil; 7. Federal University of Rio Grande do Norte, Natal, Brazil; 8. Hospital Sirio Libanes, São Paulo, Brazil; 9. Albert Einstein Hospital, São Paulo, Brazil

Source PDF DOI Publisher page
129 days

Clinical Pharmacology of Plozasiran

AuthorsJessica Huston; Dontia Orey; Kelli Corona; Andrew Ashchi; Andrea Ashchi Lachapelle; Elias Deeb; Alexander Deeb; Rambod Rouhbakhsh; Jason Berner; David Sutton; Wasim Deeb; Majdi Ashchi; Amir Azarbal; Rebecca F. Goldfaden

Affiliations1. Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, Jacksonville, USA; 2. East Coast Institute for Research, Jacksonville, USA; 3. Philadelphia College of Osteopathic Medicine - South Georgia Campus, Moultrie, USA; 4. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA; 5. Forrest General Hospital Family Medicine Residency, Hattiesburg, USA; 6. Georgia Mountain Endocrinology, Canton, USA; 7. Northeast Florida Endocrine and Diabetes Associates, Jacksonville, USA; 8. First Choice Endocrinology, Jacksonville, USA; 9. Ashchi Heart and Vascular Center, Jacksonville, USA

Source PDF DOI Publisher page
186 days

De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making

AuthorsNavid Radfar; Dhir Gala; Harsh Singh; Juan Bello; Joseph Allencherril

Affiliations1. Department of Medicine, Rutgers New Jersey Medical School, Newark, USA; 2. Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, USA; 3. Division of Cardiology, Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.